RAP 0.00% 20.5¢ resapp health limited

Highly doubt the current board would have been able to monetise...

  1. 6,500 Posts.
    lightbulb Created with Sketch. 1540
    Highly doubt the current board would have been able to monetise it. The covid study highlighted all Dx can do is gauge the severity of a cough, not differentiate between illnesses, which anyone can do.
    Use case at this point is pretty much triage only, I'll back Pfizer to turn this into a money maker, but without them this was going bankrupt.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.